The Reveal LINQ™ ICM works continuously to capture comprehensive and actionable data over a longer period of time than short-term monitors to deliver superior yield that can increase the rate of diagnosis for patients with atrial fibrillation (AF), cryptogenic stroke, and unexplained syncope.

The LUX-Dx ICM System features a dual-stage algorithm that detects and verifies data resulting in fewer false positives. Remote programming technology enables adjustments with fewer visits to clinics.

The LINQ II insertable cardiac monitor (ICM) is a small device that sends personalized information about your heart to your doctor and can watch your heart for irregular heartbeats 24/7 for up to 4.5 years.

The LUX-Dx II+™ ICM System builds upon the advanced dual-stage algorithm and unparalleled signal quality—while adding enhanced detection algorithms and monitoring capabilities to help reduce false alerts, encourage patient compliance, and prioritize clinically actionable events.

Learn more about the Reveal LINQ insertable cardiac monitor (ICM), a wireless and powerfully small ICM ideal for patients experiencing infrequent symptoms that require long-term monitoring or ongoing management.

The LUX-Dx II+ ICM is a night-and-day difference from other ICMs. It can detect, differentiate and record with separate programmed parameters for nighttime Brady and Pause events—giving clinicians the flexibility to focus on what matters, when it matters.

With Assert-IQ ICM, you will be able to detect arrhythmias more accurately, see EGM details more clearly*, and gain additional insights to enable more informed decision making, all powered by state-of-the-art Bluetooth® technology and remote programming capabilities.**

The LINQ II™ ICM enables remote programming capability for all device parameters post-insertion from the clinic, which may reduce patient office visits and scheduling hassles. Patient data transmitted to the CareLink™ network via MyCareLink™ Relay or MyCareLink Heart™ app

The LINQ II™ insertable cardiac monitoring system is the world’s most accurate ICM, 1-4 personalised for the patient’s lifestyle and customised for the clinician’s workflow. LINQ II™ ICM is ideal for patients experiencing infrequent symptoms that require long-term monitoring or …

Dec 22, 2020 · Boston Scientific has announced winning FDA clearance for its LUX-Dx Insertable Cardiac Monitor (ICM), an implant that can detect hard-to-spot cardiac arrhythmias, such as atrial fibrillation, and help diagnose their origin.